These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 649979)

  • 1. Plasma immunoreactive beta-melanocyte-stimulating hormone in chronic liver disease and fulminant hepatic failure.
    Smith AG; Shuster S; Bomford A; Williams R
    J Invest Dermatol; 1978 Jun; 70(6):326-7. PubMed ID: 649979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The pituitary hormones (beta MSH-ACTH) in hyperpigmented hepatic cirrhosis. Apropos of 10 cases].
    Valla D; Cunci O; Girard F; Thomas M
    Med Chir Dig; 1976; 5(7):329-34. PubMed ID: 190485
    [No Abstract]   [Full Text] [Related]  

  • 3. Chloasma, oral contraceptives, and plasma immunoreactive beta-melanocyte-stimulating hormone.
    Smith AG; Shuster S; Thody AJ; Peberdy M
    J Invest Dermatol; 1977 Apr; 68(4):169-70. PubMed ID: 845449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma immunoreactive beta-melanocyte-stimulating hormone and skin pigmentation in chronic renal failure.
    Smith AG; Shuster S; Comaish JS; Plummer NA; Thody AJ; Alvarez-Ude F; Kerr DN
    Br Med J; 1975 Mar; 1(5959):658-9. PubMed ID: 1125653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanin pigmentation of the skin in primary biliary cirrhosis.
    Mills PR; Skerrow CJ; MacKie RM
    J Cutan Pathol; 1981 Dec; 8(6):404-10. PubMed ID: 6278001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the kidney in regulating plasma immunoreactive beta-melanocyte-stimulating hormone.
    Smith AG; Shuster S; Thody AJ; Alvarez-Ude F; Kerr DN
    Br Med J; 1976 Apr; 1(6014):874-6. PubMed ID: 769907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanocyte-stimulating-hormone levels in doxorubicin-induced hyperpigmentation.
    Kew MC; Mzamane D; Smith AG; Shuster S
    Lancet; 1977 Apr; 1(8015):811. PubMed ID: 66615
    [No Abstract]   [Full Text] [Related]  

  • 8. Normal and abnormal regulation of beta-msh in man.
    Abe K; Nicholson WE; Liddle GW; Orth DN; Island DP
    J Clin Invest; 1969 Aug; 48(8):1580-5. PubMed ID: 4307702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma ACTH and beta-MSH in normal subjects and in pituitary-adrenal pathology and in non-endocrine pigmentation disorders].
    Usategui Echevarría R; Oliver C; Laffite JM; Jimeno Carruez A; Ortíz Manchado O; Vague J
    Rev Clin Esp; 1975 Oct; 139(2):163-9. PubMed ID: 172985
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma ACTH and melanocyte-stimulating hormone in nail pigmentation.
    Arakawa S; Takamatsu T; Imashuku S; Kusunoki T
    Arch Dis Child; 1978 Mar; 53(3):249-50. PubMed ID: 206211
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunoreactive beta-melanocyte-stimulating hormone and melanin pigmentation in systemic sclerosis.
    Smith AG; Holti GS; Shuster S
    Br Med J; 1976 Sep; 2(6038):733-4. PubMed ID: 974574
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma immunoreactive beta-melanocyte stimulating hormone (lipotropin) levels in individuals with Prader-Labhart-Willi syndrome.
    Butler MG; Jenkins BB; Orth DN
    Am J Med Genet; 1987 Dec; 28(4):839-44. PubMed ID: 3688022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperpigmentation due solely to increased plasma beta-melanotropin.
    Sawin CT; Abe K; Orth DN
    Arch Intern Med; 1970 Apr; 125(4):708-10. PubMed ID: 4314528
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunoreactive beta-melanocyte-stimulating hormone in cerebrospinal fluid and plasma in hypopituitarism: evidence for an extrapituitary origin.
    Shuster S; Smith A; Plummer N; Thody A; Clark F
    Br Med J; 1977 May; 1(6072):1318-9. PubMed ID: 861596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Melanin thesaurismosis with special reference to melanocyte stimulating hormone (MSH) secretion anomalies].
    Abe K
    Nihon Rinsho; 1972 Nov; 30(11):2243-8. PubMed ID: 4346765
    [No Abstract]   [Full Text] [Related]  

  • 16. Dynamics and characterization of plasma immunoreactive beta-melanocyte stimulating hormone in hemodialysis patients: its relationship to ACTH.
    Bertagna X; Donnadieu M; Idatte JM; Girard F
    J Clin Endocrinol Metab; 1977 Dec; 45(6):1179-86. PubMed ID: 201658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cancer of the pancreas revealed by hepatomegaly and melanoderma with increase in plasma ACTH and MSH. Valve of echotomography and tomodensitometry].
    Eugene C; Anciaux-Lespine ML; Boitard C; Quevauvilliers J
    Med Chir Dig; 1979; 8(4):287-9. PubMed ID: 228128
    [No Abstract]   [Full Text] [Related]  

  • 18. Alpha-melanocyte-stimulating hormone in primary biliary cirrhosis.
    Bergasa NV; Vergalla J; Turner ML; Loh PY; Jones EA
    Ann N Y Acad Sci; 1993 May; 680():454-8. PubMed ID: 8390167
    [No Abstract]   [Full Text] [Related]  

  • 19. Measurement of immunoreactive alpha-melanocyte-stimulating hormone in the blood of rainbow trout kept under various conditions.
    Bowley TJ; Rance TA; Baker BI
    J Endocrinol; 1983 May; 97(2):267-75. PubMed ID: 6854194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanocyte-stimulating hormone: a regulator of human melanocyte physiology.
    Hunt G
    Pathobiology; 1995; 63(1):12-21. PubMed ID: 7546272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.